Regulation Expert Witnesses
Regulatory compliance has become a service that companies purchase, and when that service fails, the resulting disputes often pit regulated businesses against the consultants and advisors they relied on to navigate agency requirements. A drug sponsor may pursue its regulatory affairs firm after a deficient submission draws a formal deficiency letter, a bank may sue the consultant that certified its anti-money laundering program as remediated, and a merging company may challenge the economic analysis that failed to persuade antitrust regulators. Comparable conflicts surface in utility rate proceedings, customs classification, insurance rate filings, and licensing. The central issue is usually whether the advice or work product conformed to what the regulatory framework and agency practice actually required at the time.
Regulatory experts reconstruct the standard against which the challenged conduct should be measured, drawing on statutes, rules, guidance, and examination practices as agencies apply them in practice rather than in theory. With that benchmark established, the expert can evaluate whether a submission, compliance program, rate model, or filing met the expectations of a reasonably competent professional in the field, which often becomes the core of a professional negligence or breach of contract claim. The analysis also addresses causation by distinguishing an adverse agency action that flowed from the defendant's error from one driven by policy shifts or circumstances outside anyone's control. Those conclusions shape how counsel quantify delay costs, retroactive assessments, or lost transactions, and how they rebut an opponent's account of what the regulator would have done.
Regulation is not a single discipline, and an expert who is persuasive on bank supervision may have little to offer on FCC processes or FDA approval pathways. Among the professionals we can present are economists who have published on antitrust and the regulation of industries, securities specialists experienced in SEC and FINRA matters, bank regulatory authorities, and pharmaceutical professionals who have written on FDA post-marketing requirements. Many have testified repeatedly on supervision, suitability, and regulatory standards, and members of this network have consulted for institutions such as the World Bank, the Federal Trade Commission, the Department of Transportation, and the Federal Reserve Bank. With more than 75,000 expert searches for litigators behind it, Round Table Group can help you pinpoint the regulatory expert your dispute requires. Tell us about your matter by calling us at (202) 908-4500.
